(Q78723657)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504054%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

How low is the alpha/beta ratio for prostate cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504054%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Jian Z Wang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504054%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

M Guerrero

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504054%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

X Allen Li

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504054%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

English

0 references

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504054%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504054%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504054%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504054%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

194-203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504054%20AND%20SRC:MED&resulttype=core&format=json

Fractionation and protraction for radiotherapy of prostate carcinoma

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Is the prostrate alpha/beta ratio of 1.5 from Brenner & Hall a modeling artifact

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Toward optimal external-beam fractionation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Is alpha/beta for prostate tumors really low?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Is the alpha/beta ratio for prostate cancer low?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

The prospects for new treatments for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

A comment on proliferation rates in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Time-dose factors in radiotherapy: a review of the human data.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Recommendations of the American Association of Physicists in Medicine on 103Pd interstitial source calibration and dosimetry: implications for dose specification and prescription

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Dose selection for prostate cancer patients based on dose comparison and dose response studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: x-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Correlation between slowly repairable double-strand breaks and thermal radiosensitization in the human HeLa S3 cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903828-2

7 January 2021

10.1016/S0360-3016(02)03828-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504054%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference